玻璃体腔内注射康柏西普治疗视网膜静脉阻塞的围手术期护理被引量：2

Perioperative nursing management for patients with intravitreal injection of Conbercept for retinal vein obstruction

下载PDF

导出

摘要本文总结了玻璃体腔内注射康柏西普治疗视网膜静脉阻塞(RVO)的围手术期护理措施,包括术前心理护理、术前准备、术中配合、术后观察和用药护理、出院指导等。

作者朱春霞 ZHU Chunxia

机构地区苏州大学附属张家港医院眼科

出处《中西医结合护理（中英文）》 2019年第7期145-146,共2页 Journal of Clinical Nursing in Practice

关键词视网膜静脉阻塞康柏西普玻璃体腔内注射围手术期护理

分类号 R473.77 [医药卫生—护理学]

引文网络
相关文献

参考文献4

1李昆,彭娟,高丹宇.康柏西普治疗渗出性年龄相关性黄斑变性的临床观察[J].国际眼科杂志,2017,17(12):2342-2344. 被引量：4
2赵洁文,李明新.玻璃体腔注射康柏西普治疗视网膜静脉阻塞继发黄斑水肿的疗效观察[J].中国眼耳鼻喉科杂志,2018,18(1):26-28. 被引量：19
3Liang Shan,Mi Zheng,Yuan Zhang,Yuan Qu,Tian Niu,Qing Gu,Xin Xia.Correlation of Vascular Endothelial Growth Factor Production with Photochemical Reaction-induced Retinal Edema[J].Chinese Medical Journal,2016(24):2944-2950. 被引量：9
4雷春燕,雷博.眼科新一代抗血管内皮生长因子药物的基础研究及临床试验进展[J].中华实验眼科杂志,2014,32(10):938-942. 被引量：38

二级参考文献43

1Wei Chen,Ying Wu,Mi Zheng,Qing Gu,Zhi Zheng,Xin Xia.Establishing an experimental rat model of photo-dynamically-induced retinal vein occlusion using erythrosin B[J].International Journal of Ophthalmology(English edition),2014,7(2):232-238. 被引量：7
2赵明威,胡庆军,黎晓新.玻璃体内注射曲安奈德治疗黄斑水肿临床研究的现状分析[J].中华眼底病杂志,2005,21(4):220-223. 被引量：24
3沈降,孙慧敏.年龄相关性黄斑变性的发病机制及治疗的研究[J].中国实用眼科杂志,2006,24(3):236-239. 被引量：19
4Semeraro F,Morescalchi F,Duse S,et al.Aflibercept in wet AM D:specific role and optimal use[J].Drug Des Devel Ther,2013,7:711-722. 被引量：1
5Dixon JA,Oliver SC,Olson JL,et al.VEGF Trap-Eye for the treatment of neovascular age-related macular degeneration[J].Expert Opin Investig Drugs,2009,18:1573-1580. 被引量：1
6Stewart MW,Grippon S,Kirkpatrick P.Aflibercept[J].Nat Rev Drug Discov,2012,11:269-270. 被引量：1
7HeierJS,Brown DM,Chong V,et al.VIEW 1 and VIEW 2 Study Groups.Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration[J].Ophthalmology,2012,119:2537-2548. 被引量：1
8Bakall B,Folk JC,Boldt HC,et al.Aflibercept therapy for exudative age-related macular degeneration resistant to bevacizumab and ranibizumab[J].Am J Ophthalmol,2013,156:15-22. 被引量：1
9Chang AA,Li H,Broadhead GK,et al.Intravitreal aflibercept fortreatment-resistant neovascular age-related macular degeneration[J].Ophthalmology,2014,121:188-192. 被引量：1
10Kumar N,Marsiglia M,Mrejen S,et al.Visual and anatomical outcomes of intravitreal aflibercept in eyes with persistent subfoveal fluid despite previous treatments with ranibizumab in patients with neovascular agerelated macular degeneration[J].Retina,2013,33:1605-1612. 被引量：1